More about

Gout

News
December 11, 2019
2 min read
Save

Naproxen better first-line gout option than colchicine in primary care

Naproxen better first-line gout option than colchicine in primary care

Although there is no significant difference between naproxen and low-dose colchicine in terms of improvements in pain intensity among patients with gout flare, naproxen causes fewer side effects, making it the superior first-line option for gout flares in primary care, according to findings published in Annals of the Rheumatic Diseases.

News
November 25, 2019
2 min read
Save

Gout linked to increased cardiovascular disease risk

Gout linked to increased cardiovascular disease risk

ATLANTA — Gout is associated with an increased risk for cardiovascular disease, as calculated via population-level cardiovascular risk equations, according to data presented at ACR/ARP 2019.

News
November 16, 2019
8 min read
Save

COLCOT: Low-dose colchicine reduces CV risk after MI

COLCOT: Low-dose colchicine reduces CV risk after MI

PHILADELPHIA — Adults with a recent MI were less likely to experience an ischemic CV event over 2 years when assigned the anti-inflammatory gout medication colchicine compared with assignment to placebo, according to new results of the COLCOT trial presented at the American Heart Association Scientific Sessions.

News
November 15, 2019
4 min read
Save

Gout guidelines call for treat-to-target strategy using allopurinol

Gout guidelines call for treat-to-target strategy using allopurinol

ATLANTA — The 2019 ACR gout guidelines call for treating patients to a target serum urate level of 6 mg/dL, a marked departure from the 2012 document, according to speakers at ACR/ARP 2019.

News
November 12, 2019
2 min read
Save

Opioid-related hospitalizations surge for rheumatic diseases, rise led by OA, fibromyalgia, RA

Opioid-related hospitalizations surge for rheumatic diseases, rise led by OA, fibromyalgia, RA

ATLANTA — The incidence of opioid-related hospitalizations among patients with musculoskeletal conditions increased markedly over the past 2 decades, with continued growth among patients with osteoarthritis, rheumatoid arthritis and fibromyalgia, according to a presentation at the 2019 ACR/ARP Annual Meeting.

News
November 11, 2019
1 min watch
Save

VIDEO: Patients who develop gout after transplantation more likely to return to dialysis

VIDEO: Patients who develop gout after transplantation more likely to return to dialysis

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results that assessed the relationship between gout and return to hemodialysis among patients who had a kidney transplant. Researchers found patients who developed gout after transplantation were more likely to need maintenance hemodialysis compared with patients without gout and those with preexisting gout.

News
November 09, 2019
3 min watch
Save

VIDEO: Patients with gout at increased risk of transplant-related complications

VIDEO: Patients with gout at increased risk of transplant-related complications

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results of a study on renal transplant patients that found those with gout had increased rates of transplant-related complications.

News
November 07, 2019
3 min read
Save

ACR to expand use of livestreams, add 'TED Talk-style' sessions for 2019 annual meeting

ACR to expand use of livestreams, add 'TED Talk-style' sessions for 2019 annual meeting

The American College of Rheumatology plans to expand its digital offerings at the 2019 ACR/ARP Annual meeting this weekend with more than 50 sessions available for livestreaming, along with a new “TED Talk-style” collection of short lectures set to tackle several “controversial issues facing rheumatologists today,” according to organizers.

News
October 13, 2019
2 min read
Save

Practitioners review steps to reduce the risk of gout in patients with CKD

Practitioners review steps to reduce the risk of gout in patients with CKD

SAN DIEGO — Once the parade of sharp crystals formed by uric acid start their march through the blood stream and emit their prickly pain to the body’s joints, H. Joseph Salameh, MD, FASN, FACP, told attendees here there are few options available to shutting down the effect short term.

News
October 08, 2019
3 min read
Save

Heart disease increases risk for severe skin reactions to allopurinol

Heart disease increases risk for severe skin reactions to allopurinol

Heart disease is associated with an increased risk for severe cutaneous adverse reactions to allopurinol, according to data published in the Canadian Medical Association Journal.

View more